Streetbeat News

Stock Prices

CLDX

Celldex Therapeutics (NASDAQ:CLDX) has announced a proposed public offering of its common stock, with the final terms dependent on market conditions. The company plans to use the proceeds for the development of its product candidates, including barzolvolimab, and for general corporate purposes. Jefferies and Leerink Partners are the joint book-running managers for the offering.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:59 pm

IDAI

T Stamp (NASDAQ:IDAI) reported Q3 sales of $3.07 million, beating the analyst consensus estimate of $1.08 million by 183.89 percent. This represents a 127.45 percent increase over sales of $1.35 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:58 pm

HOOD

Robinhood Markets Inc (NASDAQ:HOOD) reported Q3 earnings with a revenue of $467 million, missing estimates of $478.2 million, and a 9 cent loss per share, beating estimates of a 10 cent loss. Total revenues were up 29% YoY, while monthly active users decreased 16% to 10.3 million. The company increased its full-year 2023 operating expense guidance to a range of $2.399 billion to $2.439 billion. Robinhood shares were down 6.15% in after-hours trading.

Portfolio Pulse from Adam Eckert

November 07, 2023 | 9:57 pm

HOOD

Robinhood's shares are trading lower following the release of mixed Q3 financial results and the company's issued guidance.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:55 pm

FLYW

Flywire reported its Q3 financial results, which led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:53 pm

TOST

Toast Inc. reported its Q3 financial results, following which its shares traded lower.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:52 pm

OM

Outset Medical's shares are trading lower following the company's Q3 financial results, which were worse than expected.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:51 pm

ATEN

A10 Networks (NYSE:ATEN) reported its Q3 earnings, beating estimated earnings by 14.29% with an EPS of $0.16, against an estimate of $0.14. However, revenue was down $14.28 million from the same period last year. Last quarter, the company beat EPS estimates by $0.02, which led to a 5.91% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 9:50 pm

CASA

Casa Systems reported worse-than-expected Q3 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:50 pm

STE

STERIS Corporation has confirmed its fiscal 2024 outlook, expecting a reported revenue growth of 9-10% and constant currency organic revenue growth of 6-7%. The company anticipates adjusted earnings per diluted share to be in the range of $8.60 to $8.80, slightly below the estimated $8.75. The projected free cash flow for fiscal 2024 is approximately $685 million.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 9:49 pm